Lexicon Pharmaceuticals | Ventas



Sales Cambio Fecha
Abbott USD 10.36B 610M 2025-03
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
Agios Pharmaceuticals USD 8.7M 2.03M 2025-03
Alnylam Pharmaceuticals USD 594.19M 1.02M 2025-03
AstraZeneca USD 13.59B 1.3B 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Eli Lilly USD 12.73B 802.8M 2025-03
Halozyme Therapeutics USD 265M 33.01M 2025-03
Illumina USD 1.1B 24M 2024-12
Insmed USD 104.44M 11.02M 2024-12
Ironwood Pharmaceuticals USD 90.54M 1.05M 2024-12
J&J USD 21.89B 630M 2025-03
MacroGenics USD 19.35M 91.35M 2024-12
MannKind USD 76.78M 6.7M 2024-12
Merck USD 15.53B 94M 2025-03
Moderna USD 108M 858M 2025-03
Novartis USD 13.15B 330M 2024-12
PTC Therapeutics USD 190M 23.17M 2025-03
Sarepta Therapeutics USD 774.9M 116.49M 2025-03
Thermo Fisher Scientific USD 10.36B 1.04B 2025-03
Ultragenyx Pharmaceutical USD 139.29M 25.59M 2025-03
United Therapeutics USD 794.4M 58.5M 2025-03



Lexicon Pharmaceuticals Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.